1 |
| Sonographic Features of Cellulitis and Failure of Therapy |
| |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- UMASS Memorial Medical Center
Worcester, Massachusetts, United States
|
2 |
| Effectiveness of Diathermy-Radiofrecuency Compared With Cavitation in Cellulitis Treatment |
|
- Other: Experimental group
- Other: Control group
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Faculty of Nursing and Physiotherapy. University of Cadiz
Cádiz, Spain
|
3 |
| A Study Assessing the Impact of Dermatology Consultation in Patients Presenting With PossibleCellulitis |
|
- Other: Dermatology Consultation
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Prevention
|
- Massachusetts General Hospital
Boston, Massachusetts, United States
|
4 |
| Adjunctive Clindamycin for Cellulitis: C4C Trial. |
|
- Drug: Flucloxacillin and Clindamycin
- Drug: Flucloxacillin and placebo
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- University Hospitals Bristol NHS Foundation Trust
Bristol, United Kingdom
|
5 |
| Use of a Single Dose of Oral Prednisone in the Treatment of Cellulitis |
|
- Drug: Prednisone
- Drug: Placebo
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Supportive Care
|
- Albert Einstein Medical Center
Philadelphia, Pennsylvania, United States
|
6 |
| Use of Corticosteroids in Children With Cellulitis |
|
- Drug: Dexamethasone
- Drug: Normal Saline
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Hospital General de NIños Pedro de Elizalde
Buenos Aires, CF, Argentina
|
7 |
| Effect of Teledermatology on Length of Hospital Admission, Length of Stay, 30 Day Readmission Rate, and Antibiotic Use in Patients Presenting WithCellulitis vs Pseudocellulitis in an Academic ED Setting |
|
- Other: teledermatology consult
- Other: Routine Care
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Investigator)
- Primary Purpose: Supportive Care
|
- The Ohio State University Wexner Medical Center
Columbus, Ohio, United States
|
8 |
| The Effect of Dermatology and Teledermatology Consultations on Length of Hospital Admission, 30 Day Readmission Rate, and Antibiotic Use in Patients Presenting With Cellulitis vs Pseudocellulitis in an Academic Inpatient Setting |
|
- Other: teledermatology consult
- Other: Routine Care
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Investigator)
- Primary Purpose: Diagnostic
|
- The Ohio State University Wexner Medical Center
Columbus, Ohio, United States
|
9 |
| Comparison of Intravenous Cefazolin Plus Oral Probenecid With Oral Cephalexin for the Treatment of Cellulitis |
|
- Drug: IV cefazolin plus oral probenecid and placebo cephalexin
- Drug: Oral cephalexin and saline IV plus probenecid placebo
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Kelowna General Hospital
Kelowna, British Columbia, Canada
- Queen Elizabeth II Health Sciences Centre
Halifax, Nova Scotia, Canada
|
10 |
| Predictors of Oral Antibiotic Treatment Failure in Emergency Department Patients With Cellulitis |
| |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Connolly Hospital Banchardstown
Dublin 15, Ireland
- Emergency Department Beaumont Hospital
Dublin, Ireland
- Mater Misericoridiae University Hospital
Dublin, Ireland
|
11 |
| Study Assessing Impact of Dermatology Consultation for Patients Admitted With Cellulitis |
|
- Other: Dermatology consult
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Other
|
- Massachusetts General Hospital
Boston, Massachusetts, United States
|
12 |
| Predictors of Failure of Empiric Outpatient Antibiotic Therapy in Emergency Department Patients With Uncomplicated Cellulitis. |
- Uncomplicated Outpatient Cellulitis
| |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- The University of Western Ontario
London, Ontario, Canada
|
13 |
| Comparing the Intravenous Treatment of Skin Infections in Children, Home Versus Hospital |
|
- Other: Home
- Other: Ward
- Drug: ceftriaxone
- Drug: flucloxacillin
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- The Royal Children's Hospital Melbourne
Parkville, Victoria, Australia
|
14 |
| Handheld Infrared Thermometer to EvaluateCellulitis |
- Cellulitis
- Cellulitis of Arm
- Cellulitis of Leg
| |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- McGill University Health Centre
Montreal, Quebec, Canada
- Jewish General Hospital
Montreal, Quebec, Canada
|
15 |
| Study of New Antibiotic Regimen for the Treatment of Uncomplicated Cellulitis in Emergency Department Patients |
|
- Drug: trimethoprim-sulfamethoxazole
- Drug: Cephalexin
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Triple (Participant, Care Provider, Investigator)
- Primary Purpose: Treatment
|
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Brigham and Women's Hospital
Boston, Massachusetts, United States
- Children's Hospital Boston
Boston, Massachusetts, United States
|
16 |
| The Effect of Histopathologic Analysis and Tissue Cultures on Inpatient Management of Cellulitis and Pseudocellulitis |
- Cellulitis
- Pseudocellulitis
|
|
- Observational Model: Cohort
- Time Perspective: Prospective
|
- The Ohio State University Dermatology
Gahanna, Ohio, United States
|
17 |
| Far-IR Emitted by Compression Stockings forCellulitis Treatment |
- Cellulitis
- Quality of Life
|
- Other: Far-IR compression stockings
- Other: No far-IR compression stockings
|
- Allocation: Randomized
- Intervention Model: Single Group Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
| |
18 |
| Study Comparing CUBICIN® (Daptomycin for Injection) With Vancomycin in Cellulitis or Erysipelas |
|
- Drug: Daptomycin
- Drug: Vancomycin
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single
- Primary Purpose: Treatment
|
- Joseph Still Research Foundation
Augusta, Georgia, United States
|
19 |
| RCT to Investigate if Prophylactic Antibiotics Prevent Further Episodes of Cellulitis (Erysipelas) of the Leg |
- Cellulitis/Erysipelas of the Leg
|
- Drug: Penicillin VK
- Other: placebo
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Prevention
|
- South Infirmary-Victoria University Hospital
Cork, Ireland
- Queens Medical Centre
Nottingham, Nottinghamshire, United Kingdom
- Aberdeen Royal Infirmary
Aberdeen, United Kingdom
- (and 22 more...)
|
20 |
| Duration of ANtibiotic Therapy for CEllulitis |
|
- Drug: Flucloxacillin
- Drug: Placebo (for flucloxacillin)
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Flevoziekenhuis
Almere, Flevoland, Netherlands
- Sint Lucas Andreas Ziekenhuis
Amsterdam, Noord-Holland, Netherlands
- Slotervaartziekenhuis
Amsterdam, Noord-Holland, Netherlands
- (and 8 more...)
|
21 |
| The Use of Oral Steroids in the Treatment ofCellulitis |
|
- Drug: Prednisone
- Drug: Placebo Oral Tablet
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Outcomes Assessor)
- Primary Purpose: Treatment
| |
22 |
| The Effects of Daptomycin and Cytokines Production in Comparison With Vancomycin |
|
- Drug: Daptomycin
- Drug: Vancomycin
|
- Allocation: Randomized
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Basic Science
|
- Hospital Universitário Evangelico de Curitiba
Curitiba, Parana, Brazil
|
23 |
| Fast Magnetic Resonance Imaging as Compared to Computed Tomography Scan in Pediatric OrbitalCellulitis Imaging |
|
- Device: Computed Tomography Scan
- Device: Fast Magnetic Resonance Imaging
|
- Allocation: Non-Randomized
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Diagnostic
|
- Hillel Yaffe Medical Center
Hadera, Israel
|
24 |
| Penicillin for the Emergency Department Outpatient Treatment of CELLulitis |
- Cellulitis
- Wound Infection
- Abscess
|
- Drug: Flucloxacillin
- Drug: Phenoxymethylpenicillin
- Drug: Placebo (for phenoxymethylpenicillin)
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Investigator)
- Primary Purpose: Treatment
|
- Department of Emergency Medicine, Connolly Hospital,
Blanchardstown, Dublin, Ireland
- Department of Emergency Medicine, Mercy University Cork
Cork, Greenville Place, Ireland
- Department of Emergency Medicine, Cork University Hospital
Cork, Wilton, Ireland
- (and 2 more...)
|
25 |
| Oral Moxifloxacin Versus Cefazolin and Oral Probenecid in the Management of Skin and Soft Tissue Infections in the Emergency Department |
|
- Drug: Cefazolin and Moxifloxacin
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Investigator)
- Primary Purpose: Treatment
|
- St. Paul's Hospital, Providence Healthcare, Emergency Medicine
Vancouver, British Columbia, Canada
|
26 |
| Prevention of Vaginal Cellulitis or Vaginal Cuff Abscess After Laparoscopic Hysterectomy |
- Hysterectomy
- Cellulitis
- Vaginosis
- (and 2 more...)
|
- Drug: cephalosporin + Metronidazole Vaginal
- Drug: cephalosporin + Placebos
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Triple (Participant, Care Provider, Investigator)
- Primary Purpose: Prevention
|
- Clinica del prado
Medellín, Colombia
- Clínica comfamiliar pereira
Pereira, Colombia
|
27 |
| Extracorporeal Shock Wave Treatment for Cellulite |
|
- Device: Radial extracorporeal shock wave therapy
|
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Concept Clinic
Geneva, Switzerland
|
28 |
| Human Immunity Against Staphylococcus AureusSkin Infection |
- Staphylococcus Aureus Skin Infection
|
|
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Basic Science
|
- National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States
|
29 |
| Cellulite and Magnetic Resonance Imaging |
| |
- Observational Model: Case-Only
- Time Perspective: Prospective
| |
30 |
| Motorized Mechanical Massage Associated With Cosmetics in Improving Body Contour and Appearance of Gynoid Lipodystrophy |
|
- Device: Motorized mechanical massage with the Dermothonus Slim® Ibramed with cosmetics
|
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Ibramed - Indústria Brasileira de Equipamentos Médicos
Amparo, São Paulo, Brazil
|
31 |
| The Effects of Iontophoresis in Women With Gynoid Hidrolipodystrophy. |
|
- Combination Product: iontophoresis + caffeine
|
- Allocation: Randomized
- Intervention Model: Factorial Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Rodrigo Antonio Carvalho Andraus
Londrina, Paraná, Brazil
|
32 |
| A Phase 2 Safety and Exploratory Skin Lesion Measurement of TR-701 FA Study |
- Major Cutaneous Abscess
- Cellulitis
- Erysipelas
|
|
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Other
|
- Trius Investigator Site #118
Anaheim, California, United States
- Trius Investigator Site #129
Buena Park, California, United States
- Trius Investigator Site 103
Chula Vista, California, United States
- (and 7 more...)
|
33 |
| Effect of Vibro-oscillatory Therapy for Improvement of Body Contour and Appearance of Cellulite. |
- Body Fat Distribution
- Cellulitis
|
|
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Ibramed - Indústria Brasileira de Equipamentos Médicos
Amparo, São Paulo, Brazil
|
34 |
| Continuous Regional Anesthesia for Septic Limb Orthopedic Surgery |
- Osteo Arthritis
- Cellulitis
|
- Drug: Systemic analgesia + Continuous regional anesthesia
- Drug: Systemic analgesia
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- CCOM
Illkirch, Alsace, France
|
35 |
| Microbiology of Severe Acute Tonsillitis, PeritonsillarCellulitis, and Infectious Mononucleosis |
- Acute Tonsillitis
- Peritonsillar Cellulitis
- Infectious Mononucleosis
|
|
- Observational Model: Case Control
- Time Perspective: Prospective
|
- Aarhus University Hospital
Aarhus, Denmark
|
36 |
| Aquacel Versus Iodoform Gauze for Filling Abscess Cavity Following Incision and Drainage |
|
- Device: Type of dressing - Iodoform
- Device: Type of dressing - Aquacel
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Maricopa Integrated Health System
Phoenix, Arizona, United States
|
37 |
| Pharmacokinetics of Retapamulin in Pediatric Subjects With Uncomplicated Skin Infections. |
- Skin Infections, Bacterial
|
- Drug: Retapamulin Ointment, 1%
|
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- GSK Investigational Site
Tuscaloosa, Alabama, United States
- GSK Investigational Site
Bentonville, Arkansas, United States
- GSK Investigational Site
Orange, California, United States
- (and 22 more...)
|
38 |
| Daptomycin Versus Vancomycin in Participants WithSkin Infections Due to MRSA |
- Staphylococcal Skin Infections
|
- Drug: Daptomycin
- Drug: Vancomycin
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Mobile, Alabama, United States
- Chula Vista, California, United States
- Escondido, California, United States
- (and 23 more...)
|
39 |
| A Study to Evaluate Safety, Tolerability and Efficacy of Lytixar™ (LTX-109) on Uncomplicated, Gram-positive, Skin Infection |
- Gram-positive, Skin Infections
- Mild Eczema/Dermatoses
- Atopic Dermatitis
|
|
- Allocation: Randomized
- Intervention Model: Single Group Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Debreceni Egyetem Orvos-és Egészségtudományi
Debrecen, Hungary
- Miskolci Semmelweis Ignác Egészegügyi Központ és
Miskolc, Hungary
- Pécsi Tudományegyetem általános Orvostudom´nyi Centum
Pécs, Hungary
- Szeged Univesrity Hospital
Szeged, Hungary
|
40 |
| Evaluation of Daptomycin for the Emergency Department Treatment of Complicated Skin and Skin Structure Infections |
- Cellulitis
- Skin Infections
|
- Drug: Daptomycin
- Drug: Vancomycin
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- University of Cincinnati, Dept. of Emergency Medicine
Cincinnati, Ohio, United States
|
41 |
| Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections |
- Skin Infection
- Bacterial Infection
|
- Drug: Daptomycin
- Drug: Brilacidin
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- eStudy Site
Chula Vista, California, United States
- eStudy Site
La Mesa, California, United States
- eStudy Site
Oceanside, California, United States
- eStudy Site
Las Vegas, Nevada, United States
|
42 |
| Incision and Drainage Versus Needle Aspiration in Soft Tissue Abscesses |
|
- Procedure: Incision and Drainage
- Procedure: Ultrasound Guided Aspiration
|
- Allocation: Randomized
- Intervention Model: Crossover Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Beth Isreal Deaconess Medical Center
Boston, Massachusetts, United States
- University of Massachusetts
Worcester, Massachusetts, United States
|
43 |
| Bioequivalence Study for an Isotretinoin |
|
|
- Allocation: Randomized
- Intervention Model: Crossover Assignment
- Masking: None (Open Label)
- Primary Purpose: Other
|
- GSK Investigational Site
Monterrey, Nuevo León, Mexico
|
44 |
| Bioequivalence Minocycline Bioequivalence |
|
|
- Allocation: Randomized
- Intervention Model: Crossover Assignment
- Masking: None (Open Label)
- Primary Purpose: Other
| |
45 |
| Evaluation of Antibacterial Soap for Treatment of Lymphedema in a Filariasis-Endemic Area |
|
- Drug: antimicrobial agent in soap
|
- Allocation: Randomized
- Intervention Model: Single Group Assignment
- Masking: Double
- Primary Purpose: Prevention
|
- Hopital Ste. Croix
Leogane, Haiti
|
46 |
| Effectiveness of Alcohol Swabs for Preventing Infections During Vaccination |
|
- Drug: Alcohol
- Drug: No alcohol
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Triple (Participant, Care Provider, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Pediatrician Clinic
North York, Ontario, Canada
|
47 |
| Safety, Potential Efficacy, and Pharmacokinetics of PZ-601 in the Treatment of Complicated Skin and Skin Structure Infection |
|
- Drug: PZ-601
- Drug: Standard of Care
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Treatment
|
- eStudySite - Sharp Chula Vista
Chula Vista, California, United States
- Novellus Research Site
Fountain Valley, California, United States
- Novellus Research Site
Long Beach, California, United States
- (and 12 more...)
|
48 |
| The Use of Prophylactic Antibiotics in Isolated Blowout Fractures |
- Orbital Fractures
- Orbital Cellulitis
|
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Prevention
|
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
|
49 |
| A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Oral Ciprofloxacin in the Treatment of Adults With Mild to Moderate Infections of the Skin and the Supportive Layers Beneath the Skin |
- Skin Diseases, Infectious
- Cellulitis
|
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
| |
50 |
| Safety and Efficacy of Daptomycin for the Treatment of Complicated Skin and Skin-structure Infections |
- Staphylococcal Skin Infections
|
|
- Allocation: Non-Randomized
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Novartis Italy
Novartis Italy, Italy
- Novartis Italy
Saronno, Italy
|
51 |
| Retapamulin Microdialysis Feasibility Study |
- Skin Infections, Bacterial
|
- Drug: Retapamulin Microdialysis
|
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- GSK Investigational Site
Gainesville, Florida, United States
|
52 |
| Hospital Avoidance Strategies for ABSSSI |
|
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Barnes-Jewish Hospital
Saint Louis, Missouri, United States
|
53 |
| Point-of-Care Ultrasound Educational Initiative for Insect Bites |
- Cellulitis
- Insect Bites
- Insect Stings
|
- Behavioral: POCUS Educational Intervention
|
- Allocation: Non-Randomized
- Intervention Model: Sequential Assignment
- Masking: None (Open Label)
- Primary Purpose: Supportive Care
|
- Jacobi Medical Center
Bronx, New York, United States
|
54 |
| ALTARGO(Retapamulin) PMS(Post-marketing Surveillance) |
- Skin Infections, Bacterial
|
- Drug: ALTARGO(retapamulin)
|
- Time Perspective: Prospective
|
- GSK Investigational Site
Seoul, Korea, Republic of
|
55 |
| United States Pharmacovigilence Retapamulin-Prescribing |
- Skin Infections, Bacterial
|
- Drug: Retapamulin
- Drug: Co-prescription of retapamulin and topical mupirocin
|
- Time Perspective: Retrospective
| |
56 |
| Retapamulin Versus Placebo in Secondarily-Infected Traumatic Lesions (SITL) |
- Skin Infections, Bacterial
|
- Drug: Retapamulin Ointment, 1%
- Drug: Placebo ointment
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Investigator)
- Primary Purpose: Treatment
|
- GSK Investigational Site
Tucson, Arizona, United States
- GSK Investigational Site
Anaheim, California, United States
- GSK Investigational Site
Fresno, California, United States
- (and 51 more...)
|
57 |
| Shock Waves for Treatment of Gynoid Lipodystrophy and Localized Fat |
- Lipodystrophy
- Cellulitis
- Adiposity
|
- Device: THORK Shock Wave® (Extracorporeal shock waves)
|
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Ibramed - Indústria Brasileira de Equipamentos Médicos
Amparo, São Paulo, Brazil
|
58 |
| Phase 2a Study of CG400549 for the Treatment of cABSSSI Caused by Methicillin-resistant Staphylococcus Aureus |
|
|
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- eStudysite
La Mesa, California, United States
|
59 |
| Topical SB-275833 Ointment, 1% For The Treatment Of Impetigo |
- Skin Infections, Bacterial
|
- Drug: SB-275833 ointment, 1%
|
- Allocation: Randomized
- Intervention Model: Single Group Assignment
- Masking: Single (Investigator)
- Primary Purpose: Treatment
|
- GSK Investigational Site
Winnipeg, Manitoba, Canada
- GSK Investigational Site
Winnipeg, Manitoba, Canada
- GSK Investigational Site
Saint John's, Newfoundland and Labrador, Canada
- (and 66 more...)
|
60 |
| Retapamulin Versus Linezolid in the Treatment of SITL and Impetigo Due to MRSA |
- Skin Infections, Bacterial
|
- Drug: Retpamulin Ointment, 1%
- Drug: Linezolid
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Investigator)
- Primary Purpose: Treatment
|
- GSK Investigational Site
Anniston, Alabama, United States
- GSK Investigational Site
Birmingham, Alabama, United States
- GSK Investigational Site
Bentonville, Arkansas, United States
- (and 50 more...)
|
61 |
| TD-1792 in Gram-positive Complicated Skin and Skin Structure Infection |
- Staphylococcal Skin Infection
|
- Drug: TD-1792
- Drug: Vancomycin
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Allan Churukian
National City, California, United States
|
62 |
| Complicated Skin and Skin Structure Infections |
- Skin Infection
- Abscess
- Cellulitis
|
- Drug: Meropenem
- Drug: Imipenem-cilastatin
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Triple (Participant, Care Provider, Investigator)
- Primary Purpose: Treatment
| |
63 |
| Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus |
- Staphylococcal Skin Infection
|
- Drug: Telavancin
- Drug: Vancomycin
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Paradise Valley Hospital, 2400 E. 4th Street
National City, California, United States
|
64 |
| Safety and Efficacy Study of a Fluoroquinolone to Treat Complicated Skin Infections |
- Skin Structure Infections
- Bacterial Skin Diseases
- Staphylococcal Skin Infections
|
- Drug: delafloxacin
- Drug: tigecycline
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Physician Alliance Research Center
Anaheim, California, United States
- Quality of Life Medical Center, LLC
Hawaiian Gardens, California, United States
- Tri City Medical Center
Oceanside, California, United States
- (and 11 more...)
|
65 |
| A Subjective Observational Study of Patients Using Medicated Footbath/Footwash Treatment in Podiatry Care |
- Toenail Fungal Infection
- Cellulitis
- Pitted Keratolysis
- (and 2 more...)
|
- Combination Product: Footwash
|
- Observational Model: Cohort
- Time Perspective: Prospective
|
- DCABM
Land O' Lakes, Florida, United States
|
66 |
| GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection |
- Skin Infections, Bacterial
|
- Drug: GSK1322322
- Drug: Linezolid
- Drug: GSK1322322 placebo
- Drug: Linezolid placebo
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- GSK Investigational Site
Anniston, Alabama, United States
- GSK Investigational Site
Chula Vista, California, United States
- GSK Investigational Site
La Mesa, California, United States
- (and 4 more...)
|
67 |
| A Prospective Trial of Nasal Mupirocin, Hexachlorophene Body Wash, and Systemic Antibiotics for Prevention of Recurrent Methicillin Resistant Staphylococcus Aureus Infections |
- Methicillin Resistant Staphylococcus Aureus Skin Infections
|
- Drug: nasal mupirocin
- Drug: topical 3% hexachlorophene body wash
- Drug: oral anti-MRSA antibiotic
|
- Allocation: Non-Randomized
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Prevention
| |
68 |
| Evaluation of Penetration of Ceftobiprole Into Soft Tissue Determined by Microdialysis in Healthy Volunteers |
- Staphylococcal Skin Infections
- Streptococcal Infections
|
|
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Basic Science
| |
69 |
| A Single-Dose Pharmacokinetics and Safety Study of Ceftobiprole in Pediatric Patients =3 Months to <18 Years of Age |
- Staphylococcal Skin Infections
- Streptococcal Infections
|
|
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Basic Science
| |
70 |
| Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus |
- Staphylococcal Skin Infection
|
- Drug: Telavancin
- Drug: Vancomycin
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Louisiana State University Health Sciences Center, Dept of Med/ER Med
New Orleans, Louisiana, United States
|
71 |
| Soft Tissue Ultrasound of Infections |
- Soft Tissue Infections
- Cellulitis
- Abscess
|
|
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Diagnostic
|
- Rhode Island Hospital
Providence, Rhode Island, United States
|
72 |
| A Randomized Clinical Trial to Prevent Recurrent CA-MRSA Infection |
- Methicillin Resistant Staphylococcus Aureus Skin Infections
|
- Drug: mupirocin and chlorhexidine
- Behavioral: household cleaning and disinfection
- Drug: mupirocin, chlorhexidine, & household cleaning/disinfection
|
- Allocation: Randomized
- Intervention Model: Factorial Assignment
- Masking: None (Open Label)
- Primary Purpose: Prevention
|
- Kaiser Permanente, Anaheim
Anaheim, California, United States
- Kaiser Permanente, Bellflower
Bellflower, California, United States
- Kaiser Permanente, Harbor City
Harbor City, California, United States
- (and 3 more...)
|
73 |
| First Time in Man Trial for Friulimicin B |
- Community Acquired Pneumonia
- Staphylococcal Skin Infections
|
|
- Allocation: Randomized
- Intervention Model: Single Group Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Swiss Pharma Contract Ltd
Basel, Switzerland
|
74 |
| Efficacy of InteguSeal for Surgical Skin Preparation in Patients Undergoing Total Joint Replacement |
- Prosthetic Joint Infection
- Surgical Skin Infection
|
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Outcomes Assessor)
- Primary Purpose: Prevention
|
- Rothman Institute
Philadelphia, Pennsylvania, United States
|
75 |
| Methicillin-resistant Staphylococcus Aureus (MRSA) Skin and Soft Tissue Infection (SSTI) Prevention in Military Trainees |
- Staphylococcus Aureus
- MRSA Skin Infections
- Staphylococcal Skin Infections
|
- Drug: Chlorhexidine gluconate
- Other: Supplemental training, education and hygiene
|
- Allocation: Randomized
- Intervention Model: Factorial Assignment
- Masking: None (Open Label)
- Primary Purpose: Prevention
|
- Usa Meddac Mach
Columbus, Georgia, United States
|
76 |
| Pharmacokinetic Study,Ceftobiprole,Healthy Volunteers,Healthy Patients With End Stage Renal Disease |
- Staphylococcal Skin Infections
- Streptococcal Infections
|
|
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Basic Science
| |
77 |
| Comparison of Cephalexin Versus Clindamycin for Suspected CA-MRSA Skin Infections |
- Staphylococcal Infection
- Abscess
- Staphylococcal Skin Infection
- Folliculitis
|
- Drug: clindamycin
- Drug: cephalexin
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Care Provider)
- Primary Purpose: Treatment
|
- Johns Hopkins University
Baltimore, Maryland, United States
|
78 |
| Short and Long Term Outcomes of Doxycycline Versus Trimethoprim-Sulfamethoxazole for Skin and Soft Tissue Infections Treatment |
- Methicillin-resistant Staphylococcus Aureus
- Skin Infection
|
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Harbor-UCLA Medical Center
Torrance, California, United States
- Washington University
Saint Louis, Missouri, United States
|
79 |
| Clinical and Economic Outcomes of Ceftaroline Fosamil for ABSSSI Documented or at Risk of MRSA |
- Skin Diseases, Infectious
- Staphylococcal Skin Infections
|
- Drug: Ceftaroline
- Drug: Vancomycin
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Detroit Medical Center
Detroit, Michigan, United States
- St. John Hospital and Medical Center
Detroit, Michigan, United States
- Henry Ford Hospital
Detroit, Michigan, United States
|
80 |
| Hospitalization at Home: The Acute Care Home Hospital Program for Adults |
- Pneumonia
- Heart Failure
- Cellulitis
- Urinary Tract Infections
|
- Other: Home hospitalization
- Other: Inpatient Hospitalization
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Brigham and Women's Hospital
Boston, Massachusetts, United States
- Brigham and Women's Faulkner Hospital
Boston, Massachusetts, United States
|
81 |
| Safety and Efficacy Study of Oxazolidinones to Treat Uncomplicated Skin Infections |
- Infectious Skin Diseases
- Bacterial Skin Diseases
- Staphylococcal Skin Infections
- (and 2 more...)
|
- Drug: Radezolid
- Drug: Linezolid
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Drug Research & Analysis Corp
Montgomery, Alabama, United States
- OWENS Pharma Research Center
Long Beach, California, United States
- Healthcare Partners Medical Group
Los Angeles, California, United States
- (and 16 more...)
|
82 |
| A Study Evaluating the Pharmacokinetics of Ceftobiprole When Taken by Obese Patients |
- Obesity
- Staphylococcal Skin Infections
- Streptococcal Infections
|
|
- Allocation: Non-Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Basic Science
| |
83 |
| Oritavancin Versus IV Vancomycin for the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infection |
- Wound Infection
- Abscess
- Systemic Inflammation
- Cellulitis
|
- Drug: Single-Dose IV Oritavancin Diphosphate
- Drug: IV Vancomycin
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Sharp Grossmont Hospital
La Mesa, California, United States
|
84 |
| Oritavancin Versus IV Vancomycin for the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infection |
- Wound Infection
- Abscess
- Systemic Inflammation
- Cellulitis
|
- Drug: Single-Dose IV Oritavancin Diphosphate
- Drug: IV Vancomycin
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Sharp Chula Vista Medical Center
Chula Vista, California, United States
|
85 |
| Sivextro in Acute Bacterial Skin and Skin Structure Infection (ABSSSI) in Hospitalized Patients. A Global Observational Study |
- Abscess
- Cellulitis
- Erysipelas
- Wound Infection
|
- Drug: Tedizolid (Sivextro, BAY 11-70438)
- Drug: Linezolid
|
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Multiple Locations, Russian Federation
- Multiple Locations, Singapore
|
86 |
| A Complicated Skin and Soft-tissue Infection Patient Registry |
- Staphylococcal Skin Infections
- Diabetic Foot Infections
- Surgical Wound Infection
- (and 2 more...)
| |
- Time Perspective: Prospective
| |
87 |
| Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections |
- Skin Diseases, Infectious
- Skin Diseases, Bacterial
- Staphylococcal Skin Infections
|
- Drug: Ceftobiprole medocaril
- Drug: Vancomycin
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
| |
88 |
| Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections |
- Skin Diseases, Infectious
- Skin Diseases, Bacterial
- Staphylococcal Skin Infections
|
- Drug: ceftobiprole medocaril
- Drug: Vancomycin plus Ceftazidime
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
| |
89 |
| Direct Antibiotic Delivery of Cefazolin Into Soft Tissue Infections Using Subcutaneous Injection and Ultrasonic Dispersion |
- Infection, Soft Tissue
- Infection, Wound
- Cellulitis
- Diabetic Foot Ulcer
|
- Drug: Cefazolin
- Device: Silberg Tissue Preparation System
| |
- Sonoma West Medical Center
Sebastopol, California, United States
|
90 |
| China Registration Study in Patients With Skin Infections |
|
- Drug: Daptomycin
- Drug: Vancomycin
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Investigator)
- Primary Purpose: Treatment
|
- Research Site
Beijing, Beijing, China
- Research Site
Guangzhou, Guangdong, China
- Research Site
Wuhan, Hubei, China
- (and 10 more...)
|
91 |
| An Attempt to Reduce Community-Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection in Soldiers |
- Community-Acquired MRSA Infections
- Abscesses
- Cellulitis
- Folliculitis
|
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double
- Primary Purpose: Prevention
|
- Brooke Army Medical Center
Ft. Sam Houston, Texas, United States
|
92 |
| Safety and Efficacy of CEM-102 Compared to Linezolid in Acute Bacterial Skin Infections |
|
- Drug: CEM-102
- Drug: Linezolid
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Chula Vista, California, United States
- La Mesa, California, United States
- Los Angeles, California, United States
- (and 13 more...)
|
93 |
| Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With ComplicatedSkin Infections |
|
- Drug: IV Vancomycin plus IV Aztreonam
- Drug: Ceftaroline
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Investigational Site
Dothan, Alabama, United States
- Investigational Site
Long Beach, California, United States
- Investigational Site
Los Angeles, California, United States
- (and 49 more...)
|
94 |
| Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With ComplicatedSkin Infections |
|
- Drug: ceftaroline
- Drug: vancomycin plus aztreonam
- Drug: Placebo
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Investigational Site
Buena Park, California, United States
- Investigational Site
Hawaiian Gardens, California, United States
- Investigational Site
Los Angeles, California, United States
- (and 51 more...)
|
95 |
| Study Comparing the Safety and Efficacy of Tigecycline With Ampicillin-Sulbactam or Amoxicillin-Clavulanate to Treat Skin Infections |
|
- Drug: Tigecycline
- Drug: ampicillin-sulbactam
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Scottsdale, Arizona, United States
- Jonesboro, Arkansas, United States
- Chula Vista, California, United States
- (and 55 more...)
|
96 |
| Single Dose vs. Two Dose Regimen of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections |
- Abscess
- Wound Infection
- Surgical Site Infection
- Cellulitis
|
- Drug: Dalbavancin
- Drug: Dalbavancin-matching Placebo
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- 110
Montgomery, Alabama, United States
- 103
Anaheim, California, United States
- 117
Long Beach, California, United States
- (and 75 more...)
|
97 |
| Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections |
- Abscess
- Wound Infection
- Surgical Site Infection
- Cellulitis
|
- Drug: IV Dalbavancin
- Drug: Vancomycin/Linezolid
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Durata Clinical Site
Montgomery, Alabama, United States
- Durata Clinical Site
Anaheim, California, United States
- Durata Clinical Site
Buena Park, California, United States
- (and 134 more...)
|
98 |
| Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections |
- Abscess
- Wound Infection
- Surgical Site Infection
- Cellulitis
|
- Drug: Dalbavancin
- Drug: Vancomycin / Linezolid
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Durata Study Site
Anaheim, California, United States
- Durata Study Site
Azusa, California, United States
- Durata Study Site
Bellflower, California, United States
- (and 89 more...)
|
99 |
| Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA |
- Methicillin-Resistant Staphylococcus Aureus
- Bacterial Infections
- Staphylococcal Skin Infections
|
- Drug: Dalbavancin single dose
- Drug: Dalbavancin two dose
- Drug: Comparator
|
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- University of South Alabama
Mobile, Alabama, United States
- Maricopa Integrated Health System
Phoenix, Arizona, United States
- Southbay Pharma Research
La Palma, California, United States
- (and 88 more...)
|
100 |
| Rapid Test to Detect Staphylococcus Aureus in Blood and Wound Infections |
- Staphylococcus Aureus
- Staphylococcal Skin Infections
- Bacteremia
| |
- Time Perspective: Retrospective
|
- Michael E. DeBakey VA Medical Center
Houston, Texas, United States
|
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου